Serum Prolidase Enzyme Activity Level: Not a Predictive Biomarker for Epilepsy

Creative Commons License

Ayas Z. O., Kotan D., AKDOĞAN M., Gunel M. E.

EURASIAN JOURNAL OF MEDICINE, cilt.51, sa.1, ss.27-30, 2019 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 51 Sayı: 1
  • Basım Tarihi: 2019
  • Doi Numarası: 10.5152/eurasianjmed.2018.18183
  • Dergi Adı: EURASIAN JOURNAL OF MEDICINE
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.27-30
  • Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

Objective: Oxidative stress (OS) and inflammation are considered responsible for the pathogenesis of epilepsy. Prolidase has an extremely important role in proline recycling for collagen synthesis. Higher than normal proline levels have been shown to increase OS. Furthermore, prolidase activity is associated with inflammation during fibrotic process. No study has yet investigated the relationship between epilepsy and prolidase enzyme activity (PEA). In this study, we aimed to contribute to the existing literature by assessing postictal PEA levels, which are correlated with inflammation and OS, to determine whether PEA levels may be used as a biomarker for epilepsy.